Navigation Links
Haemonetics Announces Launch of Faster Plasma Collection Protocol
Date:6/16/2008

BRAINTREE, Ma., June 16 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today at the annual meeting of the Plasma Protein Therapeutics Association the launch of a plasma collection software for its PCS(R)2 plasma collection system that reduces plasma donation time by 20%.

Stephen Swenson, General Manager of Global Plasma for Haemonetics, said, "This new software system, with its faster donation times, combined with our recently launched information technology platforms that automate center operations, are significant enhancements to our product offerings. These systems help our plasma customers to better leverage their plasma collection infrastructure by increasing donor throughput and also provide the donor with a more positive donation experience."

"As the global leader in blood management solutions, we are pleased to be continually strengthening our product suite with products, information technology platforms, and business services for blood collectors and hospitals to improve patient outcomes," he added.

The PCS2 software was 510(k) cleared by the U.S. Food and Drug Administration on May 28, 2008. The software can be used with existing PCS2 devices so no device replacement or additional operator training is required. The product will be launched in limited market release, with full market release expected by year end.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com .

Contact:

Julie Fallon

Tel. (781) 356-9517

Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
2. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
3. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
4. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
5. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
6. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
7. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
8. Villa St. Benedict Announces New Web Site
9. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
10. Indevus Announces Management Changes
11. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):